Past Recipients
- 2021 Florian Lemaitre, France
for the paper: Redefining therapeutic drug monitoring of tacrolimus in liver transplantation: A target trough concentration of 4-7 ng/mL during the first month is safe and improves graft and renal function by Lemaitre, Florian PhD; Tron, Camille PhD; Renard, Thomas MD; Jézéquel, Caroline MD; Houssel-Debry, Pauline MD; Bergeat, Damien MD; Pastoret, Cédric MD; Collet, Nicolas PharmD; Petitcollin, Antoine PhD; Verdier, Marie-Clémence PhD; Bardou-Jacquet, Edouard PhD; Camus, Christophe PhD; Boudjema, Karim PhD; Bellissant, Eric PhD; Rayar, Michel MD, on behalf of the i-Trans Rennes Study Group Published in Therapeutic Drug Monitoring, Volume 42, Number 3, October 2020, p 671-678
- 2019 Kristine Hole, Norway
for the paper: Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker by Hole, Kristine MSc; Wollmann, Birgit M. MSc; Nguyen, Camilla MSc; Haslemo, Tore PhD; Molden, Espen PhD Published in Therapeutic Drug Monitoring, Volume 40, Number 4, August 2018, p 463-468
- 2017 Michael Neely, USA
for the paper: Accurately Achieving Target Busulfan Exposure in Children and Adolescents With Very Limited Sampling and the BestDose Software by Neely, Michael MD; Philippe, Michael MSc; Rushing, Teresa PharmD; Fu, Xiaowei PhD; van Guilder, Michael PhD; Bayard, David PhD; Schumitzky, Alan PhD; Bleyzac, Nathalie PharmD, PhD; Goutelle, Sylvain PharmD, PhD Published in Therapeutic Drug Monitoring, Volume 38, Number 3, June 2016, p 332-342
- 2015 Laure Elens, Belgium
for the paper: Impact of CYP3A4*22 Allele on Tacrolimus Pharmacokinetics in Early Period After Renal Transplantation: Toward Updated Genotype-Based Dosage Guidelines by Elens, Laure PhD; Capron, Arnaud PhD; van Schaik, Ron HN; De Meyer, Martine MD; De Pauw, Luc MD; Eddour, Djamila C.; Latinne, Dominique MD, PhD; Wallemacq, Pierre PharmD, PhD; Mourad, Michel MD, PhD; Haufroid, Vincent PharmD, PhD Published in Therapeutic Drug Monitoring, Volume 35, Number 5, October 2013, p 608-616
- 2013 Franck Saint-Marcoux, France
for the paper: Development and Evaluation of a Simulation Procedure to Take Into Account Various Assays for the Bayesian Dose Adjustment of Tacrolimus by Saint-Marcoux, Franck PhD, PharmD; Debord, Jean MD, PhD; Parant, François PharmD, PhD; Labalette, Myriam MD, PhD; Kamar, Nassim MD, PhD; Rostaing, Lionel MD, PhD; Rousseau, Annick PhD; Marquet, Pierre Published in Therapeutic Drug Monitoring, Volume 33, Number 2, April 2011, p 171-177
- 2011 Karl B. Scheidweiler, USA
for the paper: Pharmacokinetics of Cocaine and Metabolites in Human Oral Fluid and Correlation With Plasma Concentrations After Controlled Administration by Scheidweiler KB, Spargo EA, Kelly TL, Cone EJ, Barnes AJ, Huestis MA Published in Therapeutic Drug Monitoring, Volume 32, Number 5, October 2010, p 628-637
- 2009 Nils Tore Vethe, Norway
for the paper: Pharmacodynamics of Mycophenolic Acid in CD4+ Cells: A Single-Dose Study of IMPDH and Purine Nucleotide Responses in Healthy Individuals by Vethe, Nils Tore MScPharm; Bremer, Sara MScPharm; Rootwelt, Helge MD, PhD; Bergan, Stein PhD Published in Therapeutic Drug Monitoring, Volume 30, Number 6, December 2008, p 647-655
|
|